Vanguard Group
ADIL

Vanguard Group’s Adial Pharmaceuticals ADIL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.97K Hold
13,159
﹤0.01% 4267
2025
Q1
$8.34K Buy
+13,159
New +$8.34K ﹤0.01% 4260
2023
Q3
Sell
-203,358
Closed -$42.3K 4539
2023
Q2
$42.3K Hold
203,358
﹤0.01% 4475
2023
Q1
$71.2K Sell
203,358
-275,517
-58% -$96.4K ﹤0.01% 4433
2022
Q4
$103K Sell
478,875
-137,980
-22% -$29.7K ﹤0.01% 4388
2022
Q3
$216K Buy
616,855
+26,003
+4% +$9.11K ﹤0.01% 4404
2022
Q2
$792K Hold
590,852
﹤0.01% 4158
2022
Q1
$1.19M Hold
590,852
﹤0.01% 4156
2021
Q4
$1.6M Sell
590,852
-3,591
-0.6% -$9.69K ﹤0.01% 4123
2021
Q3
$2.55M Buy
594,443
+9,408
+2% +$40.4K ﹤0.01% 3986
2021
Q2
$1.49M Buy
585,035
+370,238
+172% +$944K ﹤0.01% 4050
2021
Q1
$520K Buy
214,797
+18,000
+9% +$43.6K ﹤0.01% 4129
2020
Q4
$335K Hold
196,797
﹤0.01% 4024
2020
Q3
$439K Sell
196,797
-86,112
-30% -$192K ﹤0.01% 3836
2020
Q2
$393K Hold
282,909
﹤0.01% 3820
2020
Q1
$368K Hold
282,909
﹤0.01% 3734
2019
Q4
$682K Hold
282,909
﹤0.01% 3730
2019
Q3
$424K Sell
282,909
-10,999
-4% -$16.5K ﹤0.01% 3848
2019
Q2
$494K Sell
293,908
-9,800
-3% -$16.5K ﹤0.01% 3829
2019
Q1
$1.04M Buy
303,708
+264,726
+679% +$908K ﹤0.01% 3620
2018
Q4
$200K Buy
+38,982
New +$200K ﹤0.01% 3904